Counseling patients with higher-risk MDS regarding survival with azacitidine therapy: are we using realistic estimates?

Counseling patients with higher-risk MDS regarding survival with azacitidine therapy: are we using realistic estimates?Counseling patients with higher-risk MDS regarding survival with azacitidine therapy: are we using realistic estimates?, Published online: 11 June 2018; doi:10.1038/s41408-018-0081-8Counseling patients with higher-risk MDS regarding survival with azacitidine therapy: are we using realistic estimates?

Source: Blood Cancer Journal - June 11, 2018 Category: Hematology Authors: Amer M. Zeidan Maximilian Stahl Michelle DeVeaux Smith Giri Scott Huntington Nikolai Podoltsev Rong Wang Xiaomei Ma Amy J. Davidoff Steven D. Gore Source Type: research